MEDPMedpace

Each row is one issuer’s token for Medpace, with the chains it is deployed on. A bold chain is one where these wallets hold a balance. Tokens are not shares: no issuer in the registry publishes a shares-per-token ratio, so a balance is counted one per share and marked where that assumption is doing work.

Tokenized versions of Medpace, the issuer behind each, the chains it is deployed on, and what these wallets hold of it.

Token	Issuer	Chains	You hold
MEDPx	xStocks	BNBINKSOLHYPEETHTONARBMNTXLYROP	—

Deployments come from the instrument registry, generated 2026-09-30. A chain listed here is one the issuer has deployed on, not a promise that a market exists on it.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Type

Common stock

Sector

Healthcare › Life Sciences Tools & Services

Exchange

Nasdaq

Listed since

Aug 11, 2016

Shares outstanding

27.91M

Employees

6,500

As the market data provider names it. Where that differs from the issuers’ name for the security, both are shown so the difference is visible.